PYRIDIN-2(1H)-ONE QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS
The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: (I) where A, U, W1, W2, W3, R1-R6, and R9 are described herein.
Saved in:
Main Authors | , , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
10.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: (I) where A, U, W1, W2, W3, R1-R6, and R9 are described herein. |
---|---|
AbstractList | The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: (I) where A, U, W1, W2, W3, R1-R6, and R9 are described herein. |
Author | ASHWELL, Susan CARAVELLA, Justin Andrew GUSTAFSON, Gary ERICSSON, Anna WANG, Zhongguo LIN, Jian LANCIA, David R. Jr CAMPBELL, Ann-Marie DIEBOLD, R. Bruce LU, Wei |
Author_xml | – fullname: LIN, Jian – fullname: CARAVELLA, Justin Andrew – fullname: DIEBOLD, R. Bruce – fullname: ERICSSON, Anna – fullname: LU, Wei – fullname: WANG, Zhongguo – fullname: GUSTAFSON, Gary – fullname: ASHWELL, Susan – fullname: LANCIA, David R. Jr – fullname: CAMPBELL, Ann-Marie |
BookMark | eNqNirsOgjAUQDvo4OsfOurQoVTjXOFqb6IttBcMEyGmTgZI8P8jJn6Aw8k5w1myWdd3ccHuee0xQyuSrTQ74SzwokTrrhNTZ-Cx0oQVBK4Dv5WkLQkMLkXymr6DqTPvLmB1AI7W4AnJ-bBm82f7GuPm5xXjZ6DUiDj0TRyH9hG7-G4g3yeHo1RSK_XH8gGrzjKS |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | DÉRIVÉS DE PYRIDIN-2-(1H)-ONE-QUINOLINONE EN TANT QU'INHIBITEURS D'ISOCITRATE DÉSHYDROGÉNASE PYRIDIN-2(1H)-ON-CHINOLIN-DERIVATE ALS INHIBITOREN DER MUTANTEN ISOCITRATDEHYDROGENASE |
ExternalDocumentID | EP4257131A3 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP4257131A33 |
IEDL.DBID | EVB |
IngestDate | Fri Oct 18 06:06:28 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP4257131A33 |
Notes | Application Number: EP20230176702 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240110&DB=EPODOC&CC=EP&NR=4257131A3 |
ParticipantIDs | epo_espacenet_EP4257131A3 |
PublicationCentury | 2000 |
PublicationDate | 20240110 |
PublicationDateYYYYMMDD | 2024-01-10 |
PublicationDate_xml | – month: 01 year: 2024 text: 20240110 day: 10 |
PublicationDecade | 2020 |
PublicationYear | 2024 |
RelatedCompanies | Forma Therapeutics, Inc |
RelatedCompanies_xml | – name: Forma Therapeutics, Inc |
Score | 3.5124283 |
Snippet | The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | PYRIDIN-2(1H)-ONE QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240110&DB=EPODOC&locale=&CC=EP&NR=4257131A3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEG8QjfqmqBG_sgez6MMiY2UbD8SMrbga6eZWEJ4ILTXhZRCZ8d_3tgD6og9NLm1zaS-9Xn_XuxahWwcgg4sVNhoK2wBQnKnRVkIa2BLWu3RcoUQZIMvscICfR61RBc03uTDlO6Ff5eOIoFES9D0v9-vljxMrKGMrVw9iDlWLxx7vBPoaHYN5AnOmB90OiaMg8nXfB0pnSadYmqZletYO2oVTtFMoAxl2i6SU5W-L0jtCezEwy_JjVFFZDR34m4_Xami_v77vBnKteqsT9BaPExpQZjTvzPDeiBjRXgeURS9QgA4AkA09Tock1bxU6w-4x7hB08inPPF40SEcB0n0RJiXEo2ykHYpj5L0FGk9wv3QgBFOttKYkHg7F-sMVbNFps6R5jpNCehiZkuzjafSFdOWLVqOwtK2sCNndVT_k83FP22X6LAQa-F0MBtXqJp_fKprMMO5uCkF-A2o9oUt |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFG8QjXhT1IifO5hFD4uMlW0ciBlbcVXo5lYQToSOmnAZRGb8931bAL3ooclL27z0vfTX118_Ebq1gDLYWGKtLrEJBMWaai0pEg0bwnhPLFtIURyQZaY_wM-j5qiE5pu7MMU7oV_F44iAqATwnhXj9fJnEcsrzlauHsQcshaPXd721DU7hvAE4Uz1Om0SBl7gqq4Lksqidt41dUN3jB20CzNsKwcDGXbySynL3xGle4j2QlCWZkeoJNMqqribj9eqaL-_3u8GcQ291TF6C8cR9SjTGne6f68FjCivA8qCHiSQPSBkQ4fTIYkVJ1b6A-4wrtE4cCmPHJ5X8MdeFDwR5sREocynHcqDKD5BSpdw19eghZOtNyYk3NpinKJyukjlGVJsq5EAu5iZid7C08QW06YpmpbEiWlgK5nVUO1PNef_lN2gis_7vQkY83KBDnIX5wsQev0SlbOPT3kFITkT14UzvwEUmogg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PYRIDIN-2%281H%29-ONE+QUINOLINONE+DERIVATIVES+AS+MUTANT-ISOCITRATE+DEHYDROGENASE+INHIBITORS&rft.inventor=LIN%2C+Jian&rft.inventor=CARAVELLA%2C+Justin+Andrew&rft.inventor=DIEBOLD%2C+R.+Bruce&rft.inventor=ERICSSON%2C+Anna&rft.inventor=LU%2C+Wei&rft.inventor=WANG%2C+Zhongguo&rft.inventor=GUSTAFSON%2C+Gary&rft.inventor=ASHWELL%2C+Susan&rft.inventor=LANCIA%2C+David+R.+Jr&rft.inventor=CAMPBELL%2C+Ann-Marie&rft.date=2024-01-10&rft.externalDBID=A3&rft.externalDocID=EP4257131A3 |